Explore the latest 8-K report from FibroGen Inc. (Ticker: FGEN) detailing significant corporate events. Stay informed about this NASDAQ-listed company's developments.
Explore Gyre Therapeutics, Inc.'s significant 8-K filing from February 14, 2025. Get insights on stock info, company details, and event-driven disclosures crucial for investors.
Explore the American Electric Power Company's 8-K filing from February 13, 2025, detailing stock info & corporate updates essential for investors.
Explore DouYu International Holdings Limited's 6-K report for January 2025, highlighting key filings, strategic insights, and management updates from Chief Strategy Officer Mingming Su.
Discover crucial insights from Li-Cycle Holdings Corp.'s 8-K filing, revealing significant events on January 13, 2025, impacting investors and stakeholders.
Discover the latest 8-K filing from Applied Digital Corporation dated January 14, 2025, detailing significant corporate events. Stay informed on APLD's developments!
Explore Caribou Biosciences' latest Form 8-K filed on January 12, 2025. Discover company details, stock info, and XBRL compliance for enhanced data analysis.
Explore Xeris Biopharma's latest 8-K filing detailing significant developments affecting stock performance. Stay informed on market movements and company updates.
Discover vital insights from Outset Medical, Inc.'s 8-K report, filed on January 7, 2025. Learn about recent developments impacting OM stock on NASDAQ.
Explore Benitec Biopharma Inc.'s amendment to Form 8-K filed on December 27, 2024, detailing important disclosures under Item 5.02. Learn more about the company and filing specifics.
Explore key insights from Supernus Pharmaceuticals Inc.'s 8-K filing, covering essential updates and financial data as of December 19, 2024. Essential for investors and analysts.
Explore Fox Corporation's 8-K filing from February 9, 2021. Discover stock class details, governance structure, and essential corporate information crucial for investors.